KeyBanc analyst Donald Hooker reiterated an Overweight rating for Cerner and raised his price target to $74 after the company’s “healthy” Q2 results, which featured “particularly strong” bookings. Looking ahead, Hooker tells investors in a research note that he is raising his revenue outlook to $5.423B from $5.361B in 2018 and to $5.816B from $5.791B in 2019 based on the visibility created by the Q2 bookings and bookings guidance.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.